Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial-Reference-Cited by-同舟云学术

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

Published:2019-09 Issue:9 Volume:7 Page:745-756
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Pascoe Steven,Barnes Neil,Brusselle Guy,Compton Chris,Criner Gerard J,Dransfield Mark T,Halpin David M G,Han MeiLan K,Hartley Benjamin,Lange Peter,Lettis Sally,Lipson David A,Lomas David A,Martinez Fernando J,Papi Alberto,Roche Nicolas,van der Valk Ralf J P,Wise Robert,Singh Dave

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference34 articles.

1. The global economic burden of asthma and chronic obstructive pulmonary disease;Ehteshami-Afshar;Int J Tuberc Lung Dis,2016

2. The clinical and economic burden of chronic obstructive pulmonary disease in the USA;Guarascio;Clinicoecon Outcomes Res,2013

3. Global burden of COPD;Lopez-Campos;Respirology,2016

4. Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials;Dransfield;Lancet Respir Med,2013

5. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations;Ferguson;Respir Med,2008

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history;Respiratory Research;2024-08-05

2. Change is in the air: key questions on the ‘Treatable Traits’ model for chronic airway diseases in primary care;npj Primary Care Respiratory Medicine;2024-07-18

3. Rebuttal From Drs Adrish and Hanania;CHEST;2024-07

4. POINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? Yes;CHEST;2024-07

5. The relevance of eosinophils in chronic obstructive pulmonary disease: inflammation, microbiome, and clinical outcomes;Journal of Leukocyte Biology;2024-06-28